Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 17.73
Key Takeaways
Risk factor
Good trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Sichuan Huiyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of anti-tumor and injection drugs. It provides products in oncology and related fields, and other areas. The company was founded in 2010 and is headquartered in Neijiang, China.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Data is available to registered users only
Buy
Sell